Invests in
Sectors:
Locations:
Min Investment:
$20,000,000.00Max Investment:
$30,000,000.00Target Investment:
$25,000,000.00
Skills
Education
- HM
- SU
- Uo
Lists including Richard
Investments
Alumis
Series C
Total Funding: $330M
Attralus
Series A
Total Funding: $200M
Pharvaris
Series B
Total Funding: $220M
Entact Bio
Series A
Total Funding: $81M
ACELYRIN
Series B
Total Funding: $560M
ImmPACT Bio
Series B
Total Funding: $140M
Ventyx Biosciences
Series A
Total Funding: $110M
Elevation Oncology
Series B
Total Funding: $65M
Aeovian Pharmaceuticals
Series A
Total Funding: $87M
Arrakis Therapeutics
Series B
Total Funding: $110M
Work Experience
2017
Managing Partner
2017
venBio is a life sciences venture capital firm that partners with industry leaders to build game-changing medicines and technologies, with a focus on novel therapeutics for unmet medical needs.
2022
Board Member
2022
2021
Board Member
2021
2020
Board Member
2020
2019
Board Member
2019
2019
Board Member
2019
Board Member
2020
Board Observer
2019
2021 - 2023
Board Member
2021 - 2023
IPO in May 2023 (NASDAQ: SLRN)
2021 - 2023
Board Member
2021 - 2023
IPO in October 2021 (NASDAQ: VTYX)